-
Lupin rolls out generic Tracleer
21 Aug 2025 18:14 GMT
… for its Abbreviated New Drug Application from the Food … and Drug Administration.
NATCO holds … day generic drug exclusivity.
[Read more: Lupin receives FDA OK … of Actelion Pharmaceuticals' Tracleer.
They are indicated for the treatment of …
-
Natco Pharma launches generic drug with 180-day exclusivity in US
20 Aug 2025 10:38 GMT
… tablets, a generic version of Tracleer, in the US for treating … partner for this product. The drug had estimated sales of USD …
-
Natco Pharma launches generic drug for PAH in the U.S.
20 Aug 2025 17:37 GMT
… , a generic version of Actelion Pharmaceuticals’ Tracleer in the U.S.
It … will have 180-day generic drug exclusivity, Natco said on Wednesday … sales data. The drug is indicated for the treatment of pulmonary arterial …
-
Natco Pharma introduces generic Bosentan in US for pulmonary arterial hypertension treatment
20 Aug 2025 08:52 GMT
… the US FDA for its Abbreviated New Drug Application and … have 180-day generic drug exclusivity.
Bosentan Tablets for … to Tracleer Tablets for Oral Suspension of Actelion Pharmaceuticals US, … Inc.
They are indicated for the treatment …
-
Optum Rx Ends Reauthorization for Many Chronic Disease Drugs
19 Mar 2025 18:04 GMT
… term condition
Requires chronic treatment
Long-term drug effectiveness is established
… Ofev
Pulmonary arterial hypertension drugs: Revatio, Liqrev, Uptravi, Tracleer, Letairis, Adcirca, … for procedures and services in Medicare Advantage plans.
The healthcare …
-
Hyderabad-based Natco Pharma gets FDA approval for marketing Bosentan Tablets in the United States
10 Feb 2025 10:54 GMT
… and Drug Administration (U.S.FDA) for Natco’s Abbreviated New Drug Application … equivalent of Tracleer Tablets for Oral Suspension of Actelion Pharmaceuticals US, Inc … Suspension are indicated for the treatment of pulmonary arterial hypertension (PAH …
-
Lupin and Natco receive US FDA approval for generic Tracleer tablets for oral suspension
10 Feb 2025 10:17 GMT
… Food and Drug Administration (FDA) for Natco … Tracleer tablets for oral suspension of Actelion Pharmaceuticals … for the treatment of pulmonary arterial … pharmaceutical products, including branded and generic formulations, complex generics, biotechnology …
-
GoodRx : 10 Bosentan (Tracleer) Side Effects and How to Manage Them
25 Jul 2024 22:38 GMT
… savings to related medications
info_outlinedPromotional disclosure … , causes, and treatments of PAH.
Portable … infection
During clinical trials, respiratory tract infections … Food and Drug Administration.
Actelion Pharmaceuticals US. (2024). Tracleer (bosentan …
-
Human medicines European public assessment report (EPAR): Tracleer, bosentan, Date of authorisation: 14/05/2002, Revision: 43, Status: Authorised
02 May 2024 13:20 GMT
Treatment of PAH
In PAH, Tracleer film-coated tablets added … than placebo (a dummy treatment) in improving the distance … support the use of the medicine in this group.
In … weeks of treatment.
Treatment of systemic sclerosis with digital ulcers
Tracleer was …
-
Managing Pulmonary Arterial Hypertension: Diagnosis, Classification, and Treatment Strategies
30 Apr 2024 02:50 GMT
… the EDN pathway include bosentan (Tracleer; Actelion Pharmaceuticals US, Inc), ambrisentan ( … and macitentan (Opsumit; Actelion Pharmaceuticals Ltd). Drugs that target the PCN pathway … going to drive your initial treatment decision.”
According to Smith, …
About
© 1995-2025